Article published In:
Information Design Journal
Vol. 25:3 (2019) ► pp.308314
References (21)
References
Black, A., Luna, P., Lund, O., & Walker, S. (2017). Information design: Research and practice. London: Routledge. DOI logoGoogle Scholar
Collins, P. H. (1990). Black feminist thought: Knowledge, consciousness, and the politics of empowerment. London: Routledge.Google Scholar
Constanza-Chock, S. (2020). Design justice: Community-led practices to build the worlds we need. Cambridge, MA: MIT press. DOI logoGoogle Scholar
European Commission. (2017). Report from the commission to the European Parliament and the Council. com(2017) 135 final. [URL]
EMA. (2017). EMA action plan related to the European Commission’s recommendations on product information. (EMA/680018/2017). [URL]
. (2020). QRD-template version 10.1 (dated 28/06/2019). [URL]
Fuchs, J. (2010). The way forward in package insert user tests from a CRO’s perspective. Drug Information Journal, 44(2), 19–129. DOI logoGoogle Scholar
Modell, W. (1967). How to stuff a stuffer and cook a wolf. Pharmacology and Therapeutics, 8(6), 775–781. DOI logoGoogle Scholar
Morris, L. A. (1989). The FDAs approach to patient package inserts: The four phases of PPIs. In: M. Bogaert, B. Vander Stacee, J-M. Kaufman, & R. Lefebvre (Eds.), Patient package inserts as a source of drug information (pp. 59–66). Amsterdam: Excerpt Medica.Google Scholar
Gibbs, S. (1990). Informing patients about medicines: An evaluation of prescription information leaflets in general practice (PhD thesis), Faculty of Medicine, University of Southampton.Google Scholar
Petterson, R. (2016). Information Design Theories. IIID Public Library. [URL]; [URL]
PIL-S study. (2014). Study on the package leaflets and the summaries of product characteristics of medicinal products for human use. [URL]
PIL-BOX study. (2014). Feasibility and value of a possible “key information section” in patient information leaflets and summaries of product characteristics of medicinal products for human use. [URL]
PubMed. (2020). [URL]
Rupf, R. (1991). Evaluation of patient-oriented drug information: Package leaflets as viewed by the patient and their impact on outpatient’s behaviour during treatment. (PhD thesis). University of Basel: Faculty of Philosophy and Natural Sciences.Google Scholar
Sless, D. (1992). What is information design? In: R. Penman & D. Sless (Eds.), Designing information for people (pp. 1–16). Canberra: Communication Research press.Google Scholar
Sless, D. & Shrensky, R. (2006). Writing about medicines for people. Australian Self-Medication Industry. [A first edition was published in 1994 by David Sless and Rob Wiseman for the Department of Health and Family Services.] [URL]
Vander Stichele, R. (2004). Impact of written drug information in patient package inserts (PhD Thesis). Ghent University, Faculty of Medicine and Health Science.Google Scholar
Van der Waarde, K. (1993). An investigation into the suitability of the graphic presentation of patient package inserts (PhD thesis). University of Reading, Department of Typography & Graphic Communication.Google Scholar
(2008). Measuring the quality of information in medical package leaflets: Harmful or helpful? Information Design Journal, 16(3), 16–228. DOI logoGoogle Scholar
Walker, S. (2017). The contribution of typography and information design to health communication. In: E. Tsekleves & R. Cooper (Eds.), Design for health (pp. 92–109). London: Routledge. DOI logoGoogle Scholar